DIA Appoints Dr. Robin Weinick as Senior Vice President and Managing Director for DIA Americas
Dr. Robin Weinick to Lead Expansion of Thought Catalyst Strategy as DIA’s Global Program Officer
DIA, the premier professional global community for healthcare product development, announced today the appointment of Robin Weinick, PhD, as Senior Vice President and Managing Director for DIA Americas, and Global Program Officer. Dr. Weinick will lead the organization’s strategic efforts to refine and evolve DIA’s thought leadership and knowledge platforms worldwide using DIA’s global platform.
Prior to joining DIA, Dr. Weinick served as Vice President, Division for Research on Healthcare Value, Equity, and the Lifespan, at RTI International, a nonprofit research institute dedicated to improving the human condition. Over a 25-year career that has spanned public service, academic, and policy research, Dr. Weinick also served as Associate Director for Health at the RAND Corporation, a premier US-based think tank, and on the faculty of Harvard Medical School and Massachusetts General Hospital. She began her career in federal service with the US Department of Health and Human Services after completing a PhD in Population Dynamics from Johns Hopkins University.
“I’m very excited to join DIA and believe that the work we can do together has the potential to contribute to an improved world,” said Dr. Weinick. “Maybe now even more at this critical moment in human history, we see how interconnected the life sciences and healthcare stakeholders are – and how dependent humankind is, globally, on innovative solutions that yield safe, effective, rapid response. I’m honored to be part of an organization that believes so deeply in collaboration across the entire global stakeholder community to bring life-saving treatments to patients.”
“We are pleased to welcome Dr. Weinick to the DIA family, and know that her broad expertise and past experiences in leading complex health organizations will allow us to continue growing our relevance and participation, not only in the Americas region, but globally as we expand our thought-leadership strategy, advance learning opportunities, and, most importantly, enhance the potential avenues for real-life benefit to patients worldwide,” said Barbara Lopez Kunz, Global Chief Executive, DIA.